399 related articles for article (PubMed ID: 21930463)
1. Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.
Tamura T; Kimura T; Morimoto T; Nakagawa Y; Furukawa Y; Kadota K; Tatami R; Kawai K; Sone T; Miyazaki S; Mitsudo K;
EuroIntervention; 2011 Sep; 7(5):588-96. PubMed ID: 21930463
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention: a meta-analysis of five clinical trials.
Qian J; Chen Z; Ma J; Ge J
Catheter Cardiovasc Interv; 2012 Oct; 80(4):507-13. PubMed ID: 22045690
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
[TBL] [Abstract][Full Text] [Related]
7. Choice of stenting strategy in true coronary artery bifurcation lesions.
Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
Abe M; Kimura T; Morimoto T; Taniguchi T; Yamanaka F; Nakao K; Yagi N; Kokubu N; Kasahara Y; Kataoka Y; Otsuka Y; Kawamura A; Miyazaki S; Nakao K; Horiuchi K; Ito A; Hoshizaki H; Kawaguchi R; Setoguchi M; Inada T; Kishi K; Sakamoto H; Morioka N; Imai M; Shiomi H; Nonogi H; Mitsudo K;
Circulation; 2010 Jul; 122(1):42-51. PubMed ID: 20566954
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry.
Kishi K; Kimura T; Morimoto T; Namura M; Muramatsu T; Nishikawa H; Hiasa Y; Isshiki T; Nobuyoshi M; Mitsudo K;
Circ Cardiovasc Interv; 2011 Aug; 4(4):362-70. PubMed ID: 21712527
[TBL] [Abstract][Full Text] [Related]
10. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.
Song PS; Ryu DR; Song YB; Hahn JY; Choi JH; Choi SH; Lee SH; Hong KP; Park JE; Gwon HC
Clin Cardiol; 2011 Jun; 34(6):378-83. PubMed ID: 21538383
[TBL] [Abstract][Full Text] [Related]
12. Comparison of target-lesion revascularisation between left main coronary artery bifurcations and left anterior descending coronary artery bifurcations using the one and two stent approach with sirolimus-eluting stents.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Okimoto T; Otsuka M; Tamekiyo H; Tamura T; Kadota K; Inoue K; Mitsudo K;
EuroIntervention; 2011 Nov; 7(7):796-804. PubMed ID: 22082575
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
Burzotta F; Trani C; Todaro D; Mariani L; Talarico GP; Tommasino A; Giammarinaro M; Niccoli G; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
JACC Cardiovasc Interv; 2011 Mar; 4(3):327-35. PubMed ID: 21435612
[TBL] [Abstract][Full Text] [Related]
14. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C
Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334
[TBL] [Abstract][Full Text] [Related]
16. 3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique.
Chue CD; Routledge HC; Ludman PF; Townend JN; Epstein AC; Buller NP; Doshi SN
Catheter Cardiovasc Interv; 2010 Mar; 75(4):605-13. PubMed ID: 20066725
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
[TBL] [Abstract][Full Text] [Related]
19. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
[TBL] [Abstract][Full Text] [Related]
20. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting.
Pan M; Medina A; Suárez de Lezo J; Romero M; Segura J; Martín P; Suárez de Lezo J; Hernandez E; Mazuelos F; Ojeda S
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1165-70. PubMed ID: 22511299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
